Skip to Main Content

Paper Details

Factors Associated With PCSK9 Inhibitor Initiation Among US Veterans.
J Am Heart Assoc
9
2021
LDL-, LDL-C, PCSK9, PCSK9i, atherosclerotic cardiovascular disease, cholesterol, chronic kidney disease, ezetimibe, familial hypercholesterolemia, hypercholesterolemia, low-density lipoprotein cholesterol, patient, proprotein convertase subtilisin/kexin type 9, severe hypercholesterolemia, statin, veterans
Author NameAffiliation
Keri L MondaCenter for Observational Research and Medical Affairs Amgen Inc Thousand Oaks CA.
Ann Marie NavarUniversity of Texas Southwestern Medical Center Dallas TX.
Megan E VannemanDivision of Health System Innovation and Research Department of Population Health Sciences University of Utah School of Medicine Salt Lake City UT.
Megan E VannemanDivision of Epidemiology Department of Internal Medicine University of Utah School of Medicine Salt Lake City UT.
Megan E Vanneman
  • 1 - 5

Datasets

Release 1.2